# Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease

> **NCT07712016** · — · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University** · enrollment: 27000 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)
- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Muco-active agents
- **OTHER:** No muco-active agent use

## Key facts

- **NCT ID:** NCT07712016
- **Lead sponsor:** Seoul National University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 27000 (ESTIMATED)
- **Last updated:** 2026-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07712016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07712016, "Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07712016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*